Category - Pharma Industry News
Arcus, Gilead prep Phase III studies of anti-TIGIT domvanalimab
‘New’ GSK spotlights growth potential of vaccines and speciality medicines
Biogen plans confirmatory trial as FDA documents show struggle over Aduhelm approval
Sanofi, Translate Bio launch early study of mRNA flu vaccine
Oxford University to study antiparasitic drug ivermectin in COVID-19 trial
Global consortium of medicines regulators reveals new strategic plan
Merck’s Keytruda improves outcomes for metastatic cervical cancer patients
Novartis reveals long-term results for MS therapy Kesimpta